Diabetic Foot





KEY FACTS





  • Diabetes mellitus is a multisystem disease resulting from defects in insulin secretion &/or resistance to insulin action, which culminates in systemic hyperglycemia, which can have negative effects, especially when chronically elevated.




    • The total prevalence of diabetes in the USA was 30.3 million people (9.4% of the population) in 2015, an increase of 50% since 2002. It is estimated that ~ 30% of all diabetics are undiagnosed.




  • The socioeconomic costs (direct and indirect) of diabetes were ~ $245 billion in 2012, a number that has almost doubled since 2002. An estimated 50% of the total costs for a diabetic hospital admission are due to diabetic foot complications.




    • Diabetic foot complications are the most common cause of atraumatic lower extremity amputations and are the leading cause of hospitalization among diabetics in the USA. Foot complications have a negative impact on the health-related quality of life of a diabetic patient, with fear of ulceration, recurrent infection, and potential lifelong disability.



    • There is currently no cure for diabetes, and treatment is based on preventing and managing the complications, requiring a multidisciplinary team approach and patient compliance.








A 64-year-old male patient with severe hindfoot Charcot and complete disassociation of the talus from the rest of the foot is shown. He was literally walking on the underside of his talus with skin breakdown in that area.








The patient is essentially weight bearing on the talus directly and had a medial wound in that area. The superior surface of the calcaneus is seen superior to the level of the ankle mortise.








Severe Charcot midfoot with complete collapse of the arch is shown. The plantar prominence is readily apparent here; the risk for a plantar wound is significant. An equinus contracture often plays a large role in this midfoot “break.”








The same patient shows essentially a dorsolateral subluxation midfoot injury in which the midfoot was the inflection point with the foot dorsiflexing and everting through the midfoot.






Diabetic Vascular Disease


Background





  • Peripheral arterial occlusive disease is 4x more prevalent in diabetics than in nondiabetics. It tends to occur at an earlier age in diabetics, and the risk of disease increases with the duration of diabetes.



  • The calcification of atherosclerotic plaques in arteries of diabetic patients is more diffuse and occurs within the tunica media of the arteries, producing a lead pipe appearance on plain radiographs (as opposed to plaques in nondiabetic patients, which are patchy and occur in the tunica intima).



  • The arterial occlusion of the proximal large vessels is similar to that in nondiabetics; however, the macrovascular disease is more diffuse in diabetics distal to the popliteal trifurcation. Distal vascular procedures have proven to be helpful in diabetic patients.



  • Microvascular complications of diabetes (neuropathy, retinopathy, and nephropathy) and macrovascular complications (peripheral vascular disease, coronary artery disease, hypertension, hyperlipidemia, and cerebrovascular disease) together contribute to diabetic foot problems.



Evaluation





  • A detailed history should be obtained, including a history of smoking, hypertension, and hyperlipidemia. Patients with advanced disease will complain of claudication.



  • Pain due to vascular claudication is usually relieved with rest. However, ischemic foot pain can also occur at rest.



  • On physical examination, absent popliteal or posterior tibial pulses, thin or shiny skin, absence of hair on the foot or leg, thickened nails, and dependent rubor are all signs of vascular insufficiency.



  • Any patient with signs of advanced vascular disease (such as a history of claudication, nonhealing ulcers, or nonpalpable pulses) should be evaluated by a vascular specialist.



Diagnostic Tests





  • Noninvasive vascular tests include the ankle-brachial index (ABI) using Doppler ultrasound pressures, transcutaneous oxygen (TcpO2) measurement (oximetry), the absolute toe systolic pressure (plethysmography), Doppler waveform analysis, and segmental Doppler limb pressures and pulse volume recordings.



  • Arterial pressure readings can be falsely elevated due to rigid arterial calcification in diabetics, which may artificially raise the ABI to > 1.00. Despite that, an ABI of < 0.80 is generally considered abnormal and < 0.45 in a diabetic patient is suggestive of limb-threatening ischemia.



  • Absolute toe pressures may be more predictive of distal wound healing with toe systolic pressure < 45 mm Hg indicating poor wound-healing potential and < 30 mm Hg indicating critical limb ischemia.



  • Transcutaneous oxygen measurement < 20-30 mm Hg represents poor wound-healing potential.



  • When assessing Doppler waveform recordings, a triphasic waveform is normal. Biphasic (loss of reverse flow in early diastole) and monophasic waveforms suggest advanced occlusive disease. If lower extremity ischemia is strongly suspected, arteriography, magnetic resonance angiography, or computed tomography angiography should be performed to assess the vascular flow.





Diabetic Neuropathy


Background





  • Peripheral neuropathy is the most common cause of diabetic foot complications. The presence of neuropathy (diabetic or otherwise) greatly increases the risk of complications from any surgery.



  • Diabetic neuropathy can involve the sensory, motor, and autonomic pathways.



  • Diabetic neuropathy has been estimated to occur in 58% of patients with longstanding disease, although 1 study noted that close to 80% of diabetic patients having surgery had some degree of neuropathy.



Sensory Neuropathy





  • The earliest finding in diabetic neuropathy is vibratory and proprioceptive loss. Signs and symptoms are variable but include paresthesias, burning sensations, hyperpathia, and dysesthesias and usually reveal a symmetric sensory loss in a “stocking-glove” distribution.



  • Due to the loss of protective (pain) sensation, foot ulceration generally occurs by repetitive trauma in areas of high mechanical pressure.



  • The 5.07 (10-g monofilament) Semmes-Weinstein monofilament (SWM) test of 7-10 plantar foot sites is the recommended screening test for a patient at risk for ulcer formation due to loss of protective sensation. However, up to 10% of patients who pass the SWM test may still develop skin breakdown.



  • A simplified screening test has been described. If a patient cannot sense the touch of a 4.5-g/4.65 SWM when it is pressed under the 1st metatarsal head with just enough pressure to bend the filament, the patient should be considered at risk for ulceration.



Autonomic Neuropathy





  • Denervation of the eccrine and apocrine glands and arteries leads to abnormal thermoregulation and interference with the normal hyperemic response to infection.



  • There is decreased sweating and loss of skin temperature regulation, causing dry, cracked skin and fissure formation, which predispose to infection by allowing a portal for bacterial entry.



  • Autonomic neuropathy can also cause orthostatic hypotension; cardiovascular, urinary, and gastrointestinal problems; and erectile dysfunction. It may produce chronic venous swelling, usually requiring management with compression stockings.



Motor Neuropathy





  • Motor neuropathy can cause muscle weakness and intrinsic muscle atrophy in the feet. The resulting muscle imbalance leads to claw toe and other forefoot deformities.



  • Metatarsophalangeal hyperextension and a distally displaced fat pad accentuate pressure under the metatarsal heads with risk for ulceration.



  • Proximal interphalangeal flexion can cause pressure on the dorsum of the toe against the toe box of a shoe, and distal interphalangeal flexion can lead to increased pressure at the end of the toe, both common areas for ulceration.



Neuropathic Pain





  • Although the etiology remains unclear, diabetic patients with decreased sensation may experience neuropathic pain resulting from small nerve fiber injury or from injury to the central or peripheral nervous system.



  • Patients generally complain of burning or shooting pain that may be worse at night, and they may experience allodynia or anesthesia dolorosa.



  • Neuropathic pain can be treated with low-dose antidepressants (amitriptyline, duloxetine), anticonvulsants (gabapentin, pregabalin), analgesics (tramadol), or local topical agents (capsaicin cream, lidocaine).



  • Surgical decompression of lower extremity peripheral nerves has been reported to relieve pain and restore sensation, but this approach is controversial and should be considered experimental.





Healing in Diabetes





  • Delayed osseous and soft tissue healing is common in diabetics. Wound-healing potential is multifactorial and is largely dependent on an individual’s vascular and cardiopulmonary status, while nutritional, endocrine, metabolic, and immune status all play a significant role. Smoking and certain medications (immunosuppressant medications) can impede healing; their use should be sought.




    • Nutritional parameters suggested for successful wound healing include the following.




      • Total lymphocyte count > 1,500/microL



      • Serum albumin > 3.5 g/dL



      • Total protein > 6.2 g/dL





  • Wound healing also requires adequate wound oxygenation. This can be accomplished by optimizing the patient’s cardiac, renal, and vascular status; edema reduction; and occasionally using hyperbaric oxygen therapy.



  • Impaired fracture healing in diabetes has been linked to defects in type X collagen expression, abnormal chondrocyte maturation, and altered expression of genes that regulate osteoblast differentiation.



  • Poor glucose control and insulin deficiency will affect wound and fracture healing.



  • Measurement of glycosylated hemoglobin (HbA1c) levels is the best method for medium- to long-term diabetic control monitoring (follows glycemic control over an 8- to 10-week period) with HbA1c levels of 7% or less yielding the best outcomes. HbA1c levels > 7.5% have been correlated with a higher risk of postoperative surgical site infection.





Equinus Contracture in Diabetes





  • Many diabetic patients develop an equinus contracture for uncertain reasons.



  • Gastrocnemius contracture is assessed by measuring passive ankle dorsiflexion with the knee flexed and then extended. Limited dorsiflexion (< 5°) with the knee extended implies gastrocnemius tightness, whereas limited dorsiflexion ± knee extension implies Achilles tightness.



  • An equinus contracture increases pressures across the arch and in the forefoot. This increased pressure may lead to ulceration, especially in the forefoot, and may be a contributing factor in the development of neuropathic degeneration (rocker-bottom deformity).



  • Gastrocnemius or Achilles tendon lengthening decreases forefoot pressures and has been shown to decrease the incidence of forefoot reulceration in patients with previous ulcers. Gastrocnemius lengthening should be considered for any “at-risk” patient, which includes any patient with neuropathy. Achilles lengthening can be considered if the entire Achilles tendon is tight.





Diabetic Foot Care and Ulcer Prevention





  • Foot ulcers are all too common in diabetics. Prevention of ulceration through foot-specific patient education, routine foot screening examinations, routine (daily) nail and skin care (oils or creams with lanolin can be used for dry, cracked skin to help prevent skin breakdown), and use of appropriate footwear and orthoses are recommended.



  • Inappropriate shoewear can cause abnormal pressure to the skin, potentially causing more dorsal ulcers. Hypertrophic nails can damage the soft tissues surrounding the nails. To help avoid an ingrown toenail, nails should be cut transversely.



Prescription Footwear





  • An insensate foot in poorly fitting shoes is one of the most common causes for a diabetic ulcer.



  • The optimal shoe is an extra depth shoe that will allow for a custom insole.



  • Footwear options include a shoe with a padded heel counter and a wide and deep toe box, Plastizote shoe, Carville sandal (most accommodating for forefoot and hindfoot deformity), deep walking shoe, wide sneaker, or custom-made shoe.



  • Insoles are the mainstay of long-term nonoperative management of the diabetic foot to decrease plantar pressure and must be made out of accommodative material. Insoles are generally custom molded with dual layers; the upper layer should consist of a soft polyethylene foam (Plastizote or Pelite), which is most effective in “force distribution” to protect the plantar skin.



  • As of April 1, 2004, the Medicare Therapeutic Shoe Bill covers 1 of the following for each diabetic individual (who qualifies under Medicare part B) in 1 calendar year: 1 pair of custom-molded shoes and 2 pairs of inserts or 1 pair of extra depth shoes and 3 pairs of inserts.





Foot and Ankle Ulcers


Background





  • Diabetic foot ulcers are the most common diabetic foot complication, and foot infection is the most common reason for a diabetic hospitalization in the USA.



  • 15% of diabetic patients will develop a foot ulcer during their lifetime. Diabetic foot ulcers precede 85% of nontraumatic lower extremity amputations and are generally preceded by the triad of neuropathy, deformity, and repetitive trauma.



Pathophysiology





  • The most common risk factor for developing a diabetic foot ulcer is peripheral neuropathy. Diabetic foot ulcers commonly occur in areas of structural deformity, forming over areas of bony prominences and high pressure.



  • The area of maximum soft tissue damage secondary to vertical stress and shear occurs at the edge of pressure application (“edge effect”).



  • Ulcers can be neuropathic or ischemic.




    • Neuropathic ulcers are caused by pressure or by shear forces and generally have a healthy bed of granulation tissue beneath a necrotic cap.



    • Ischemic ulcers with underlying vascular insufficiency are usually painful and generally have a necrotic base. Ischemic ulcers should be evaluated by a vascular surgeon for limb salvage.




  • Diabetic individuals with sensory neuropathy generally lack sensation to deep pressure or pain. Loss of protective sensation due to peripheral sensory neuropathy, combined with unaccommodated structural foot deformities, commonly results in unrecognized acute or repetitive foot trauma (most commonly due to inappropriate footwear), leading to the development of ulcers with a risk of infection and possible amputation (pressure + neuropathy = ulceration).



Classification of Diabetic Foot Ulcers





  • Widely used classification systems are based on wound depth and appearance.



  • Neuropathic ulcers are generally not painful, whereas ischemic ulcers are often painful.



  • Consider biopsy for a chronic nonhealing ulcer to rule out the possibility of a Marjolin ulcer (squamous cell carcinoma arising from a chronic wound) or malignant melanoma.



Treatment





  • Assuming appropriate medical management to optimize the systemic diabetes, treatment strategy includes ulcer bed preparation, local wound care with wound dressings, and protection and offloading.




    • Ulcer bed preparation includes debridement of necrotic or infected tissue to viable margins and callus removal.



    • Local wound care




      • The most commonly used dressing is a normal saline moist to dry dressing, which acts to debride the superficial layer when removed.



      • Absorbents (alginate or Hydrofiber) can be used for exudative wounds.



      • Occlusive hydrocolloids, hydrogels, and debriding agents (including hypertonic saline gel) are appropriate for necrotic wounds. Foams can be used for exudative or necrotic wounds.



      • Collagen dressings can be used for granulating or necrotic wounds. Transparent films (Opsite, Tegaderm) are helpful for dry granulating wounds without exudate. Antimicrobial dressings, including iodine- and silver-impregnated dressings, have also been used.



      • Dressings with biologically active wound-healing agents may promote healing in wounds with reasonable healing potential, including those with a cellulose and collagen framework (Promogran), hyaluronic acid ester (Hyalofill), those that deliver platelet-derived growth factors [becaplermin gel (Regranex)], and those that apply living fetal foreskin cells (Apligraf, Dermagraft).



      • A negative-pressure wound dressing (vacuum-assisted closure technique) has also been used to successfully treat nonhealing diabetic wounds.




    • Protection and offloading include casts, removable CAM walkers (which can be wrapped to ensure compliance), splints, or orthoses.




      • Total contact casting (gold standard) is an effective method to heal plantar ulcers with a reported mean healing time of ~ 39 days. Total contact casts may decrease plantar pressure at the ulcer site by distributing force over an increased weight-bearing area, may reduce shear forces and vertical plantar pressures, can protect from trauma, can immobilize the ulcer edges, and can reduce edema.



      • Initially, the total contact cast should be changed every 5-14 days due to the potential for extreme changes in soft tissue swelling, and a poorly fitted cast may lead to skin abrasion. Initial non-weight-bearing status is preferred, although moderate early weight bearing only minimally reduces the time to healing of plantar ulcers and may improve patient compliance.



      • The most common complication of total contact casting is recurrent ulceration. Contraindications to total contact casting include active infection, arterial insufficiency, poor skin quality, and poor patient compliance.



      • Treatment for the “at-risk” foot (grade 0) involves patient education, regular clinical examination, accommodative footwear, and pressure-dissipating orthotics. When a structural deformity or prominence is present that cannot be accommodated by external modalities, deformity correction or removal of the bony prominence is recommended to prevent ulceration.



      • Grades 1 and 2 ulcers require debridement of the necrotic or infected tissue, local wound care, and offloading/pressure relief techniques (external or surgical). Dressings and topical treatment abet the healing process. Once the ulcer has healed, patients should use offloading devices to help prevent reulceration.



      • Surgery is indicated when external accommodative modalities are not successful. Achilles tendon lengthening may help reduce the recurrence of neuropathic plantar forefoot ulcers in patients with limited ankle dorsiflexion by reducing peak plantar forefoot pressures. A heel ulcer is the most difficult to manage and most commonly requires surgery.



      • Operative treatment is generally necessary for grade 3 ulcers and those with associated gangrene, which commonly require debridement of infected or gangrenous tissue with partial- or whole-foot amputation and culture-specific parenteral antibiotic therapy.





Infection





  • Wound infections may occur as a result of abnormal white blood cell function, poor nutrition and glycemic control, and the presence of peripheral vascular disease.



  • Antibiotics generally should not be used to treat a foot ulcer unless there are clinical signs of infection or underlying osteomyelitis. Infections related to superficial ulceration and cellulitis are most commonly caused by aerobic gram-positive cocci or occasionally by enteric gram-negative bacilli, which can be safely treated by a 1st-generation cephalosporin or clindamycin.



  • Diabetic deep wound infections with associated necrosis or gangrene are most commonly polymicrobial with both aerobic and anaerobic (“fetid foot”) organisms and can be initially treated with broad-spectrum antibiotics. Swab cultures of the ulcer or sinus tract are generally not reliable.



  • Whenever bone is exposed in an ulcer, it should be considered infected. Osteomyelitis in an ulcer should be treated by surgical resection of the infected bone, in whole or in part, with antibiotic therapy.



  • Soft tissue gas in a diabetic is most commonly caused by aerobic organisms or by mixed gram-negative rods, but Clostridium perfringens and necrotizing fasciitis, which is a surgical emergency, must be ruled out.


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 29, 2019 | Posted by in ORTHOPEDIC | Comments Off on Diabetic Foot

Full access? Get Clinical Tree

Get Clinical Tree app for offline access